Cargando…
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
Inhibitors of the secretion of cancer exosomes, which promote cancer progression and metastasis, may not only accelerate exosome biology research but also offer therapeutic benefits for cancer patients. Here we identify sulfisoxazole (SFX) as an inhibitor of small extracellular vesicles (sEV) secret...
Autores principales: | Im, Eun-Ju, Lee, Chan-Hyeong, Moon, Pyong-Gon, Rangaswamy, Gunassekaran Gowri, Lee, Byungheon, Lee, Jae Man, Lee, Jae-Chul, Jee, Jun-Goo, Bae, Jong-Sup, Kwon, Taeg-Kyu, Kang, Keon-Wook, Jeong, Myeong-Seon, Lee, Joo-Eun, Jung, Hyun-Suk, Ro, Hyun-Joo, Jun, Sangmi, Kang, Wonku, Seo, Seung-Yong, Cho, Young-Eun, Song, Byoung-Joon, Baek, Moon-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437193/ https://www.ncbi.nlm.nih.gov/pubmed/30918259 http://dx.doi.org/10.1038/s41467-019-09387-4 |
Ejemplares similares
-
Reply to ‘Sulfisoxazole does not inhibit the secretion of small extracellular vesicles’
por: Lee, Chan-Hyeong, et al.
Publicado: (2021) -
Peptides as multifunctional players in cancer therapy
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2023) -
Epigenetic therapy reprograms M2-type tumor-associated macrophages into an M1-like phenotype by upregulating miR-7083-5p
por: Vadevoo, Sri Murugan Poongkavithai, et al.
Publicado: (2022) -
Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
por: Shin, Jung Min, et al.
Publicado: (2021) -
Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer
por: Gangadaran, Prakash, et al.
Publicado: (2022)